News | April 19, 2024
Fresenius Kabi USA flies complaint against NATCO Pharma
Natco Pharma intends to defend the matter accordingly
Natco Pharma intends to defend the matter accordingly
FDA has concluded that this inspection is 'closed'
Ofloxacin Ophthalmic Solution USP 0.3% is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers
Submission based on results from pivotal phase III trial showing all primary endpoints met
NM5072 is an anti-Properdin antibody that selectively blocks the alternative pathway while maintaining the integrity of the classical pathway required for fending off infections
Longest survival follow-up ever reported for immunotherapy treatment in this setting
SELARSDI is approved for both adult and pediatric indications and is the second biosimilar approved under the strategic partnership between Alvotech and Teva
KRKA holds 51% and Laurus Labs holds 49% shareholding
The demand in Africa for COVID-19 vaccines has declined
_256_384.jpg)
This facility manufactures APIs & formulations of oncology and non-oncology products.
Subscribe To Our Newsletter & Stay Updated
